What is the FDA’s position on using social media to market FDA-regulated products? Who has responsibility for social media content? Should pharmaceutical and medical device companies have a social networking policy? These are just a few of the questions that are top-of-mind for health care marketers and manufacturers interested in using social media to promote their products and engage online.
Download our white paper on Social Media, Healthcare and Navigating Regulatory Issues
In November 2009, Larry Weber, Chairman of Digital Influence Group, had a discussion with Joe Shields, Product Director of Enbrel at Pfizer and Marc Reisler and Michael Manthei, Partners at Holland & Knight, about the ways marketers in the health care industry can successfully navigate regulatory issues and maximize their online presence. View the webinar below:
Navigating Regulatory Isses of Social Media in Healthcare : Webinar from Digital Influence Group on Vimeo.
Comments